Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-12-15 Sale | 2021-12-17 5:20 pm | Prelude Therapeutics Inc | PRLD | Morosini Deborah EVP, Chief of Clinical Affairs | 28,751 | $13 | $373,763 | 271,489 (Direct) | View |
| 2021-11-16 Sale | 2021-11-18 6:42 pm | Prelude Therapeutics Inc | PRLD | Morosini Deborah EVP, Chief of Clinical Affairs | 28,751 | $15.88 | $456,532 | 196,489 (Direct) | View |
| 2021-04-29 Sale | 2021-04-30 6:22 pm | Prelude Therapeutics Inc | PRLD | Morosini Deborah EVP, Chief of Clinical Affairs | 3,223 | $40.29 | $129,853 | 4,767 (Direct) | View |
| 2021-04-08 Sale | 2021-04-15 7:11 pm | Prelude Therapeutics Inc | PRLD | Morosini Deborah EVP, Chief of Clinical Affairs | 100 | $40 | $4,000 | 7,990 (Direct) | View |
| 2021-04-07 Sale | 2021-04-09 5:52 pm | Prelude Therapeutics Inc | PRLD | Morosini Deborah EVP, Chief of Clinical Affairs | 1,000 | $40.04 | $40,043 | 8,090 (Direct) | View |
| 2020-09-29 Purchase | 2020-09-29 8:08 pm | Prelude Therapeutics Inc | PRLD | Morosini Deborah EVP, Chief of Clinical Affairs | 444 | $19 | $8,436 | 444 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-02-15 Option Award | 2022-02-17 7:08 pm | N/A 2032-02-14 | Prelude Therapeutics Inc | PRLD | Morosini Deborah EVP, Chief of Clinical Affairs | 90,000 | $0 | 90,000 (Direct) | View |
| 2021-12-15 Exercise | 2021-12-17 5:20 pm | N/A 2030-03-26 | Prelude Therapeutics Inc | PRLD | Morosini Deborah EVP, Chief of Clinical Affairs | 28,751 | $0 | 271,489 (Direct) | View |
| 2021-12-15 Exercise | 2021-12-17 5:20 pm | N/A N/A | Prelude Therapeutics Inc | PRLD | Morosini Deborah EVP, Chief of Clinical Affairs | 25,735 | $12.85 | 271,489 (Direct) | View |
| 2021-12-15 Exercise | 2021-12-17 5:20 pm | N/A N/A | Prelude Therapeutics Inc | PRLD | Morosini Deborah EVP, Chief of Clinical Affairs | 3,016 | $1.89 | 271,489 (Direct) | View |
| 2021-11-16 Exercise | 2021-11-18 6:42 pm | N/A 2030-09-01 | Prelude Therapeutics Inc | PRLD | Morosini Deborah EVP, Chief of Clinical Affairs | 28,751 | $0 | 196,489 (Direct) | View |
| 2021-11-16 Exercise | 2021-11-18 6:42 pm | N/A N/A | Prelude Therapeutics Inc | PRLD | Morosini Deborah EVP, Chief of Clinical Affairs | 28,751 | $12.85 | 196,489 (Direct) | View |
| 2021-07-20 Option Award | 2021-07-22 6:14 pm | N/A 2031-07-19 | Prelude Therapeutics Inc | PRLD | Morosini Deborah EVP, Chief of Clinical Affairs | 85,000 | $0 | 85,000 (Direct) | View |
| 2021-04-29 Exercise | 2021-04-30 6:22 pm | N/A 2030-03-26 | Prelude Therapeutics Inc | PRLD | Morosini Deborah EVP, Chief of Clinical Affairs | 3,223 | $0 | 4,767 (Direct) | View |
| 2021-04-29 Exercise | 2021-04-30 6:22 pm | N/A N/A | Prelude Therapeutics Inc | PRLD | Morosini Deborah EVP, Chief of Clinical Affairs | 3,223 | $1.89 | 4,767 (Direct) | View |
| 2021-04-08 Exercise | 2021-04-15 7:11 pm | N/A 2030-03-26 | Prelude Therapeutics Inc | PRLD | Morosini Deborah EVP, Chief of Clinical Affairs | 100 | $0 | 7,990 (Direct) | View |
| 2021-04-08 Exercise | 2021-04-15 7:11 pm | N/A N/A | Prelude Therapeutics Inc | PRLD | Morosini Deborah EVP, Chief of Clinical Affairs | 100 | $1.89 | 7,990 (Direct) | View |
| 2021-04-07 Exercise | 2021-04-09 5:52 pm | N/A 2030-03-26 | Prelude Therapeutics Inc | PRLD | Morosini Deborah EVP, Chief of Clinical Affairs | 1,000 | $0 | 8,090 (Direct) | View |
| 2021-04-07 Exercise | 2021-04-09 5:52 pm | N/A N/A | Prelude Therapeutics Inc | PRLD | Morosini Deborah EVP, Chief of Clinical Affairs | 1,000 | $1.89 | 8,090 (Direct) | View |
Ownership | 2020-09-24 7:23 pm | N/A 2030-03-26 | Prelude Therapeutics Inc | PRLD | Morosini Deborah EVP, Chief of Clinical Affairs | 0 | $0 | 332,870 (Direct) | View |